Immunomodulatory drugs in the treatment of postpartum endometritis

Puerperium pyoinflammatory diseases (PID) represent the most crucial problem in obstetrics. Among the PID pathologies, the leading place belongs to postpartum endometritis, most commonly occurring after surgical and pathological childbirth. Given the fact that in the pathogenesis of postpartum PID the significant role belongs to changes in the immunological status characterized either by the combined inhibition of T- and B-systems of immunity or, primarily, by damage to T-lymphocytes, the inclusion of immunomodulatory drugs in the complex therapy of postpartum endometritis contributes to a more rapid achievement of clinical effect and allows to obtain favorable outcomes.